A Three-Dimensional Microporous Decalcified Bone Matrix Combined with Bone Marrow Mesenchymal Stem Cells Enhances Bone Regeneration in Critical-Sized Calvarial Defect of Nude Mouse
Authors:
- 13 October 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 8 (11) , 9754-9765
Abstract
The clinical repair of bone defects is hindered by limitations in donor material and complications arising from autologous bone grafting. Consequently, the development of efficient bone regeneration materials is of great clinical importance. The present study investigated a three-dimensional microporous demineralized bone matrix (DBM) combined with bone marrow mesenchymal stem cells (BMSCs) to enhance the outcomes of bone defect repair. The DBM has been developed to enhance the collagen preparation process, with the aim of retaining the collagen fiber network of the natural bone matrix and forming a three-dimensional microporous structure with good mechanical property. In vitro experiments demonstrated that the biocompatibility of DBM was superior to that of traditional cancellous and cortical bone materials, and they promoted cell adhesion, proliferation, and osteogenic differentiation as well as osteogenesis-related genes. In vivo experimentation was conducted to verify the efficacy of the treatment on a critical-sized cranial bone defect in nude mice. Micro-CT and histological analysis showed more formation of bone at 4 weeks and 8 weeks postsurgery. The DBM with optimized pore structure, degradation rate, and bioactivity enhanced the efficiency of bone defect repair by synergizing the osteogenic activity of BMSCs. The DBM with a porous and cross-linked structure could provide BMSCs with more internal surface area for attachment space to promote cell adhesion and growth and create advantages for the bone formation. Moreover, the DBM contains multifarious osteoinductive growth factors such as transforming growth factor-β (TGF-β), fibroblast growth factors (FGFs), bone morphogenetic proteins (BMPs) and insulin growth factors (IGFs), which can enhance osteogenic differentiation of BMSCs. This study may provide an innovative strategy for bone regeneration and bone defect repair.Keywords
This publication has 44 references indexed in Scilit:
- Fostering tissue engineering and regenerative medicine to treat musculoskeletal disorders in bone and muscleBioactive Materials, 2024
- Bone Regeneration with Mesenchymal Stem Cells in Scaffolds: Systematic Review of Human Clinical TrialsStem Cell Reviews and Reports, 2024
- Self‐Assembled Nanocomposite Hydrogels as Carriers for Demineralized Bone Matrix Particles and Enhanced Bone RepairAdvanced Healthcare Materials, 2024
- TNF‐α‐Induced KAT2A Impedes BMMSC Quiescence by Mediating Succinylation of the Mitophagy‐Related Protein VCPAdvanced Science, 2023
- Comparison of osteogenesis of bovine bone xenografts between true bone ceramics and decalcified bone matrixJournal of Materials Science: Materials in Medicine, 2022
- Laminin alpha 4 promotes bone regeneration by facilitating cell adhesion and vascularizationActa Biomaterialia, 2021
- Impaired Bone Regenerative Effect of Exosomes Derived from Bone Marrow Mesenchymal Stem Cells in Type 1 DiabetesStem Cells Translational Medicine, 2019
- Demineralized bone matrix as a vehicle for delivering endogenous and exogenous therapeutics in bone repairAdvanced Drug Delivery Reviews, 2012
- Ectopic bone formation associated with mesenchymal stem cells in a resorbable calcium deficient hydroxyapatite carrierBiomaterials, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001